» Articles » PMID: 38674496

-Noxious Weed or Sustainable Source of Bioactive Lignans?

Overview
Journal Plants (Basel)
Date 2024 Apr 27
PMID 38674496
Authors
Affiliations
Soon will be listed here.
Abstract

(L.) Hoffm. (Apiaceae), commonly known as wild chervil, has gained scientific interest owing to its diverse phytochemical profile and potential therapeutic applications. The plant, despite being categorized as a noxious weed, is traditionally used in treating various conditions like headaches, dressing wounds, and as a tonic, antitussive, antipyretic, analgesic, and diuretic. Its pharmacological importance stems from containing diverse bioactive lignans, especially aryltetralins and dibenzylbutyrolactones. One of the main compounds of , deoxypodophyllotoxin, among its wide-ranging effects, including antitumor, antiproliferative, antiplatelet aggregation, antiviral, anti-inflammatory, and insecticidal properties, serves as a pivotal precursor to epipodophyllotoxin, crucial in the semisynthesis of cytostatic agents like etoposide and teniposide. The main starting compound for these anticancer medicines was podophyllotoxin, intensively isolated from , now listed as an endangered species due to overexploitation. Since new species are being investigated as potential sources, emerges as a highly promising candidate owing to its abundant lignan content. This review summarizes the current knowledge on , investigating its biological and morphological characteristics, and pharmacological properties. Emphasizing the biological activities and structure-activity relationship, this review underscores its therapeutic potential, thus encouraging further exploration and utilization of this valuable plant resource.

Citing Articles

Comparative Efficacy of Azithromycin and Clarithromycin in the Management of Helicobacter pylori Infection.

Alhijazien S, Daoud S, Alzayadi M, Al Sarhan M, Aldomi M, Al Shawabkeh T Cureus. 2024; 16(10):e72033.

PMID: 39569309 PMC: 11578150. DOI: 10.7759/cureus.72033.

References
1.
Julsing M, Vasilev N, Schneidman-Duhovny D, Muntendam R, Woerdenbag H, Quax W . Metabolic stereoselectivity of cytochrome P450 3A4 towards deoxypodophyllotoxin: In silico predictions and experimental validation. Eur J Med Chem. 2007; 43(6):1171-9. DOI: 10.1016/j.ejmech.2007.09.005. View

2.
Muto N, Tomokuni T, Haramoto M, Tatemoto H, Nakanishi T, Inatomi Y . Isolation of apoptosis- and differentiation-inducing substances toward human promyelocytic leukemia HL-60 cells from leaves of Juniperus taxifolia. Biosci Biotechnol Biochem. 2008; 72(2):477-84. DOI: 10.1271/bbb.70570. View

3.
Koulman A, Bos R, Medarde M, Pras N, Quax W . A fast and simple GC MS method for lignan profiling in Anthriscus sylvestris and biosynthetically related Plant species. Planta Med. 2001; 67(9):858-62. DOI: 10.1055/s-2001-18849. View

4.
Inamori Y, Kubo M, Tsujibo H, Ogawa M, Baba K, Kozawa M . The biological activities of podophyllotoxin compounds. Chem Pharm Bull (Tokyo). 1986; 34(9):3928-32. DOI: 10.1248/cpb.34.3928. View

5.
Wang Y, Wang B, Guerram M, Sun L, Shi W, Tian C . Deoxypodophyllotoxin suppresses tumor vasculature in HUVECs by promoting cytoskeleton remodeling through LKB1-AMPK dependent Rho A activatio. Oncotarget. 2015; 6(30):29497-512. PMC: 4745742. DOI: 10.18632/oncotarget.4985. View